Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

224 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 157,497,497 shares of 171,717,172 outstanding shares and own 91.72% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), VANGUARD GROUP INC (14,463,614 shares), BlackRock, Inc. (11,742,147 shares), Casdin Capital, LLC (9,251,108 shares), Bellevue Group AG (7,377,184 shares), NORGES BANK (5,917,515 shares), JPMORGAN CHASE & CO (5,517,516 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,280,291 shares), STATE STREET CORP (4,300,216 shares), and Nextech Invest Ltd. (3,846,409 shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.